[HTML][HTML] COVID-19 vaccines: modes of immune activation and future challenges
JR Teijaro, DL Farber - Nature Reviews Immunology, 2021 - nature.com
The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide
dissemination across the global population and the inclusion of newly licensed mRNA …
dissemination across the global population and the inclusion of newly licensed mRNA …
[HTML][HTML] COVID-19 vaccines: modes of immune activation and future challenges
JR Teijaro, DL Farber - Nature Reviews. Immunology, 2021 - ncbi.nlm.nih.gov
The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide
dissemination across the global population and the inclusion of newly licensed mRNA …
dissemination across the global population and the inclusion of newly licensed mRNA …
COVID-19 vaccines: modes of immune activation and future challenges.
JR Teijaro, DL Farber - Nature reviews. Immunology, 2021 - europepmc.org
The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide
dissemination across the global population and the inclusion of newly licensed mRNA …
dissemination across the global population and the inclusion of newly licensed mRNA …
COVID-19 vaccines: modes of immune activation and future challenges
JR Teijaro, DL Farber - Nature reviews. Immunology, 2021 - pubmed.ncbi.nlm.nih.gov
The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide
dissemination across the global population and the inclusion of newly licensed mRNA …
dissemination across the global population and the inclusion of newly licensed mRNA …
[HTML][HTML] COVID-19 vaccines: modes of immune activation and future challenges
JR Teijaro, DL Farber - Nature Reviews Immunology, 2021 - nature.com
The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide
dissemination across the global population and the inclusion of newly licensed mRNA …
dissemination across the global population and the inclusion of newly licensed mRNA …
COVID-19 vaccines: modes of immune activation and future challenges.
JR Teijaro, DL Farber - Nature Reviews Immunology, 2021 - go.gale.com
The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide
dissemination across the global population and the inclusion of newly licensed mRNA …
dissemination across the global population and the inclusion of newly licensed mRNA …
[引用][C] COVID-19 vaccines: modes of immune activation and future challenges
JR Teijaro, DL Farber - Nature Reviews Immunology, 2021 - cir.nii.ac.jp
COVID-19 vaccines: modes of immune activation and future challenges | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
COVID-19 vaccines: modes of immune activation and future challenges
JR Teijaro, DL Farber - Nature reviews. Immunology, 2021 - pubmed.ncbi.nlm.nih.gov
The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide
dissemination across the global population and the inclusion of newly licensed mRNA …
dissemination across the global population and the inclusion of newly licensed mRNA …